Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Industry Celebrates Inaugural Canadian Waterpower Day
-
Fossil Announces Further Extension of Exchange Offer for Its Senior Notes
-
European Employees Fall Behind North America in AI Adoption, Raising Concerns over Readiness
-
Most Employees Still Unprepared for AI at Work, Perceptyx Research Finds
-
Fiverr Survey Debunks Gig Economy Myths: Freelancers Lead With Discipline, Flexibility, and AI
-
Zymeworks to Report Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025
-
KBR Secures $98.7 Million Space Force Contract to Advance Digital Engineering Ecosystem
-
Global Net Lease Announces Release Date for Third Quarter 2025 Results
-
Form 8.3 - Unite Group plc.
-
Director/PDMR Shareholding
-
Top African Economies Now Shield 95% of GDP from Climate Risk, GCA Index Finds
-
Form 8.3 - Empiric Student Property Plc
-
Supplement to the notice of the Extraordinary General Meeting issued on 1 October 2025
-
Form 8.3 - [IQE PLC - 15 10 2025] - (CGAML)
-
MADD Canada and NLC Partner to Fight Impaired Driving Among Newfoundland and Labrador Youth
-
Media Advisory: MADD Canada to Hold Memorial Monument Ceremony for Newfoundland and Labrador Victims and Survivors of Alcohol and Drug-Related Crashes
-
Transaction in Own Shares
-
Lakeland Capital Exceeds $250 Million in Transactions, Expands in Southeast
-
HelloRide Partners with EngageLab to Achieve Global User Operations in Shared Mobility
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ME GROUP INTERNATIONAL PLC - Ordinary Shares
-
Canadian Home Sales Mark Four-Year High for the Month of September
-
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
-
CREA Updates Resale Housing Market Forecasts for 2025 and 2026
-
Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads
-
ENT and Allergy Associates, LLP Welcomes Ethan Moritz, MD to Its Offices in Woodbury and Voorhees, NJ
-
Aicuris Announces Pritelivir Met Primary Endpoint in Immunocompromised Patients with Refractory Herpes Simplex Virus in Phase 3 Pivotal Trial
-
Form 8.5 (EPT/RI) - NCC Group plc
-
Form 8.5 (EPT/RI) - PRS REIT Plc
-
Form 8.5 (EPT/RI) - Treatt plc
-
Form 8.5 (EPT/RI) - Dowlais Group plc
-
Form 8.5 (EPT/RI) Greencore Group Plc
-
Correction: Form 8.3 - Frenkel Topping Group plc - Octopus Investments
-
CoinEx Charity Expands Its “Bridge to Hope” Mission with Starlink Deployment at the Philippines’ PDEA Academy
-
Form 8.3 - Unite Group plc
-
Humanoid Global Reports Progress on Cartwheel Robotics’ Flagship Humanoid Yogi
-
Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference
-
Commodity trade faces geopolitical turbulence, Willis reports
-
Share Buyback Transaction Details October 9 – October 15, 2025
-
Cointelegraph Research releases comprehensive HTX ventures report on market trends and digital asset outlook
-
Ekspress Grupp’s subsidiary Delfi Latvia facing contractual dispute regarding advertising sales
-
Conference on Zhu Xi's doctrine and global civilizations dialogue kicks off
-
Conference on Zhu Xi's doctrine and global civilizations dialogue kicks off
-
Facephi Unveils its Fraud Intelligence Report 2025: “Identity at Risk”
-
Facephi Unveils its Fraud Intelligence Report 2025: “Identity at Risk”
-
Bitwise accelerates staking momentum with Celestia ETP launch on Euronext Paris
-
TVM Capital Life Science Portfolio Company Smart Reporting to Acquire Fluency for Imaging - Uniting to Create Jacobian™ and Accelerate AI-Powered Reporting
-
Municipality Finance issues a USD 25 million tap under its MTN programme
-
Nasdaq Embeds Innovative AI Capabilities Within its Surveillance Platform
-
Securonix Named a Leader for Sixth Consecutive Time in the 2025 Gartner® Magic Quadrant™ for Security Information and Event Management
-
Enterome receives FDA Fast Track designation in follicular lymphoma for lead OncoMimics™ immunotherapy EO2463
